Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Dysphasia

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44366   clinical trials with a EudraCT protocol, of which   7389   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    10 result(s) found for: Dysphasia. Displaying page 1 of 1.
    EudraCT Number: 2007-006749-42 Sponsor Protocol Number: 31350 Start Date*: 2009-01-09
    Sponsor Name:University of Nottingham
    Full Title: Safety and efficacy of clopidogrel when added to aspirin and dipyridamole in high risk patients with recent ischaemic stroke or TIA: a randomised controlled trial
    Medical condition: Ischaemic stroke and TIA (transient ischaemic attack)
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029205 - Nervous system disorders 10042244 Stroke LLT
    14.1 10029205 - Nervous system disorders 10044390 Transient ischaemic attack PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended) DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2009-010761-22 Sponsor Protocol Number: 82/09 Start Date*: 2009-04-25
    Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
    Full Title: ECG changes and C-protein level variations during and after treatment with atorvastatin at different dosages in the secondary prevention of stroke.
    Medical condition: Stroke
    Disease: Version SOC Term Classification Code Term Level
    9.1 10055221 Ischemic stroke LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2014-000096-80 Sponsor Protocol Number: 01 Start Date*: 2016-08-25
    Sponsor Name:University or Tromsø
    Full Title: Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST)
    Medical condition: Acute ischaemic stroke upon awakening ("wake-up stroke")
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004852 10055221 Ischemic stroke LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed) FI (Completed) GB (GB - no longer in EU/EEA) LT (Completed) LV (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-005244-16 Sponsor Protocol Number: CDiffPrevTrial1 Start Date*: 2009-06-26
    Sponsor Name:Wrightington, Wigan and Leigh NHS Trust
    Full Title: Probiotics for the prevention of Antibiotics associated diarrhoea and Clostridium difficile associated diarrhoea A multi-centre, double-blind, randomized placebo controlled trial
    Medical condition: Prevention of Clostridium Difficile associated diarrhoea.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10012748 Diarrhoea, Clostridium difficile LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2006-003479-11 Sponsor Protocol Number: 06/Q2604/75 Start Date*: 2007-05-22
    Sponsor Name:North Staffordshire Combined Healthcare Trust
    Full Title: The Stroke Oxygen Study. A randomised controlled study of the benefits and risks of routine oxygen treatment after acute stroke
    Medical condition: Acute Stroke
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2009-010721-39 Sponsor Protocol Number: NXN-188-202 Start Date*: 2009-04-27
    Sponsor Name:Peer Tfelt-Hansen
    Full Title: A phase 2a Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks with Aura
    Medical condition: MIgraine with aura
    Disease: Version SOC Term Classification Code Term Level
    9.1 10027607 Migraine with aura LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-003551-18 Sponsor Protocol Number: AMASCIS-01/2011 Start Date*: 2012-07-23
    Sponsor Name:FIBHULP
    Full Title: Reparative Therapy In Acute Ischemic Stroke With Alogeneic Mesenchymal Stem Cells From Adipose Tissue. Safety Assessment. A Randomised, Double Blind Placebo? Controlled Single Center Pilot Clinical...
    Medical condition: acute ischemic stroke
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029205 - Nervous system disorders 10061256 Ischaemic stroke PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-004505-16 Sponsor Protocol Number: CONVINCE Start Date*: 2016-08-08
    Sponsor Name:University College Dublin
    Full Title: CONVINCE - (COlchicine for preventioN of Vascular Inflammation in Non- CardioEmbolic stroke) – a randomised clinical trial of low-dose colchicine for secondary prevention after stroke
    Medical condition: The prevention of recurrent stroke and coronary events (fatal and non- fatal) after ischaemic stroke and transient ischaemic attack (TIA) not caused by cardiac embolism or other causes unrelated to...
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029205 - Nervous system disorders 10044376 Transient cerebrovascular events HLT
    20.0 100000004866 10008205 Cerebrovascular embolism and thrombosis HLT
    22.1 10029205 - Nervous system disorders 10023027 Ischaemic stroke NOS LLT
    21.1 100000004866 10051615 Atherosclerotic cardiovascular disease LLT
    20.0 10029205 - Nervous system disorders 10007962 Central nervous system vascular disorders NEC HLT
    20.0 10029205 - Nervous system disorders 10007963 Central nervous system vascular disorders HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IE (Completed) ES (Completed) GB (GB - no longer in EU/EEA) DE (Completed) CZ (Completed) DK (Completed) PT (Completed) BE (Completed) LT (Completed) NL (Completed)
    Trial results: View results
    EudraCT Number: 2004-003116-33 Sponsor Protocol Number: 20030185 Start Date*: 2005-04-11
    Sponsor Name:Swedish Orphan Biovitrum (Sobi) AB (publ)
    Full Title: A Phase 2 Study to Evaluate the Efficacy and Safety of Palifermin (Recombinant Human Keratinocyte Growth Factor) in the Reduction of Dysphagia in Patients Receiving Concurrent Chemoradiotherapy fo...
    Medical condition: Dysphasia
    Disease: Version SOC Term Classification Code Term Level
    14.1 10017947 - Gastrointestinal disorders 10013950 Dysphagia PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2004-003870-27 Sponsor Protocol Number: RA2363 Start Date*: 2008-10-08
    Sponsor Name:University of Nottingham
    Full Title: ENOS: Efficacy of Nitric Oxide in Stroke. Estudio ENOS: Eficacia del óxido nítrico en el ictus
    Medical condition: Hipertensión en el ictus agudo
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) DK (Completed) SE (Completed) GR (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed Dec 17 12:46:18 CET 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA